Elevated LCN2 expression has been associated with ferroptosis resistance, increased tumor aggressiveness, and poor clinical outcomes in various cancers (16–19), suggesting its potential relevance in OS pathophysiology. This evidence concerns the gene LCN2 and neoplasm.